1 Min Read
LONDON, Dec 21 (Reuters) - EMA: * European medicines agency starts review of tredaptive, pelzont and trevaclyn
agency issues interim advice * Ema - started a review of the safety and efficacy of tredaptive, pelzont and
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.